First Look Analysts Research Calls for Tuesday, March 28

Photo of Paul Ausick
By Paul Ausick Published
This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them.
First Look Analysts Research Calls for Tuesday, March 28

© Mario Tama / Getty Images News via Getty Images

This report was sent to Briefing.com subscribers earlier today. 

Upgrades:

> Array Tech (ARRY) upgraded to Buy from Hold at Truist; tgt $26

> Carnival (CCL) upgraded to Equal Weight from Underweight at Wells Fargo; tgt $9

> Ciena (CIEN) upgraded to Strong Buy from Outperform at Raymond James; tgt raised to $70

> Easterly Government Properties (DEA) upgraded to Buy from Neutral at Compass Point; tgt $17

> Elevance Health (ELV) upgraded to Outperform from Sector Perform at RBC Capital Mkts; tgt raised to $572

> Encore Capital (ECPG) upgraded to Buy from Neutral at Janney

> FactSet (FDS) upgraded to Neutral from Sell at Redburn

> Genesco (GCO) upgraded to Buy from Neutral at Seaport Research Partners; tgt $50

> Occidental Petro (OXY) upgraded to Outperform from Market Perform at TD Cowen; tgt raised to $70

> PagSeguro Digital (PAGS) upgraded to Buy from Neutral at Citigroup; tgt $12

> Paramount Global (PARA) upgraded to Buy from Neutral at BofA Securities; tgt raised to $32

> Parsons (PSN) upgraded to Outperform from Mkt Perform at William Blair

> The Real Brokerage (REAX) upgraded to Buy from Long-Term Buy at Singular Research; tgt $2.20

Downgrades:

> Fox Corporation (FOXA) downgraded to Neutral from Buy at BofA Securities; tgt lowered to $34

> iHeartMedia (IHRT) downgraded to Underperform from Neutral at BofA Securities; tgt lowered to $4

> Marathon Petroleum (MPC) downgraded to Neutral from Overweight at JP Morgan; tgt raised to $149

> Williams Cos (WMB) downgraded to Hold from Buy at Truist; tgt $31

Others:

> Astria Therapeutics (ATXS) initiated with an Outperform at Evercore ISI; tgt $18

> Blink Charging (BLNK) initiated with an Equal Weight at Barclays; tgt $11

> Bowlero (BOWL) initiated with a Buy at Stifel; tgt $26

> Carrier Global (CARR) initiated with an Outperform at Oppenheimer; tgt $51

> Foghorn Therapeutics (FHTX) initiated with a Buy at BofA Securities; tgt $10

> Geron (GERN) initiated with a Neutral at Goldman; tgt $3

> Gritstone bio (GRTS) initiated with a Buy at B. Riley Securities; tgt $8

> Lennox Int’l (LII) initiated with a Perform at Oppenheimer

> Repligen (RGEN) initiated with a Buy at The Benchmark Company; tgt $230

> Trane (TT) initiated with a Perform at Oppenheimer

> Ulta Beauty (ULTA) initiated with a Buy at Canaccord Genuity; tgt $622

Photo of Paul Ausick
About the Author Paul Ausick →

Paul Ausick has been writing for a673b.bigscoots-temp.com for more than a decade. He has written extensively on investing in the energy, defense, and technology sectors. In a previous life, he wrote technical documentation and managed a marketing communications group in Silicon Valley.

He has a bachelor's degree in English from the University of Chicago and now lives in Montana, where he fishes for trout in the summer and stays inside during the winter.

Featured Reads

Our top personal finance-related articles today. Your wallet will thank you later.

Continue Reading

Top Gaining Stocks

CBOE Vol: 1,568,143
PSKY Vol: 12,285,993
STX Vol: 7,378,346
ORCL Vol: 26,317,675
DDOG Vol: 6,247,779

Top Losing Stocks

LKQ
LKQ Vol: 4,367,433
CLX Vol: 13,260,523
SYK Vol: 4,519,455
MHK Vol: 1,859,865
AMGN Vol: 3,818,618